转录因子Islet-1调节糖尿病引起的内血液视网膜屏障破坏
Nan Wang1,2,3,4, Fei Yao1,2,3,4, Wenji Xu1,2,3,4
1Eye Center of Xiangya Hospital, Central South University, Changsha, China.
Investigative ophthalmology & visual science
|October 3, 2025
概括
升高的Islet-1 (胰岛素基因增强蛋白Isl-1) 表达会通过破坏内部血视网膜屏障 (iBRB) 来恶化糖尿病视网膜病变. 针对Islet-1可能为糖尿病眼病提供一种新的治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病视网膜病变 (DR) 是导致视力丧失的主要原因.
- 内部血视网膜屏障 (iBRB) 功能障碍是DR的一个关键特征.
- 转录因子Islet-1 (胰岛素基因增强蛋白Isl-1) 在iBRB分解中的作用尚未完全理解.
研究的目的:
- 调查Islet-1在糖尿病视网膜病变中的iBRB干扰中的作用.
- 阐明Islet-1对iBRB功能障碍的分子机制.
- 在临床样本和DR的实验模型中分析Islet-1表达.
主要方法:
- 使用免疫光染色,西部斑点和qRT-PCR来评估Islet-1表达.
- 调节了岛屿-1表达,以评估其对iBRB完整性的影响.
- 在高血糖症下对人类视网膜微血管内皮细胞和糖尿病小鼠模型进行了实验.
主要成果:
- 随着DR进展和iBRB分解,观察到岛屿-1表达的增加.
- 岛屿-1上调与增加的血管内皮生长因子A (VEGFA) 表达相关.
- 岛屿-1的过度表达导致紧结蛋白Occludin和Zonula occludens-1 (ZO-1) 的水平降低.
结论:
- 岛屿-1是糖尿病视网膜病变中iBRB干扰的关键调节器.
- 岛屿-1通过增加VEGFA和减少紧结蛋白来促进iBRB分解.
- 准岛屿-1过度表达是DR的潜在治疗策略.
相关概念视频
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Insulin: The Receptor and Signaling Pathways
2.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K


